๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Compound trial record
Trackers Drugs Trial finder
Compound · clinical trials

Pyrazinamide

Source: ClinicalTrials.gov, U.S. National Library of Medicine — the 7 trials in our India and China registers that name Pyrazinamide as an intervention. Synced 24 Sep 2026
7Trials tracked
4Recruiting now
5Lead sponsors
2Country registers
Maintained by Sreepriya Prasannan
MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 โ€” Top 14 finalist
Compiled from ClinicalTrials.gov registry records ยท Last verified ยท Editorial standards

Pyrazinamide is named as a drug or biological intervention in 7 clinical trials in our India and China trial registers, 4 of which are recruiting. Lead sponsors include National Institute of Allergy and Infectious Diseases (NIAID) (3), Indian Council of Medical Research (1) and Johns Hopkins University (1). Registered phases: Phase 3 and Phase 2. Conditions studied include Pulmonary Tuberculosis; Tuberculous Meningitis; Tuberculosis.

01

Clinical trials of Pyrazinamide

7 trials
NCT IDStudyPhaseStatusLead sponsorRegister
NCT06253715 Shortened Regimen for Drug-susceptible TB in Children (ClinicalTrials.gov ↗)
Tuberculosis, Tuberculosis, Pulmonary, Tuberculosis, Lymph Node
Phase 3 Recruiting Johns Hopkins University India
NCT06905522 A PAN-USR TB Multi-Center Trial (ClinicalTrials.gov ↗)
Pulmonary Tuberculosis
Phase 3 Recruiting Shenzhen Third People's Hospital China
NCT05383742 Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis (ClinicalTrials.gov ↗)
Tuberculous Meningitis
Phase 2 Recruiting National Institute of Allergy and Infectious Diseases (NIAID) India
NCT06192160 Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis (ClinicalTrials.gov ↗)
Pulmonary Tuberculosis
Phase 2 Recruiting National Institute of Allergy and Infectious Diseases (NIAID) India
NCT05917340 Intensified Short Course Regimen for TBM in Adults (ClinicalTrials.gov ↗)
Tuberculous Meningitis
Phase 3 Not yet open Indian Council of Medical Research India
NCT07595042 A Trial of Stratified Patient-Centered Treatment Regimens for Active TB (SPECTRA-TB) (ClinicalTrials.gov ↗)
Tuberculosis
Phase 2 Not yet open National Institute of Allergy and Infectious Diseases (NIAID) India
NCT06081361 Innovating Shorter, All- Oral, Precised, Individualized Treatment Regimen for Rifampicin Resistant Tuberculosis๏ผšContezolid, Delamanid and Bedaquiline Cohort (ClinicalTrials.gov ↗)
Pulmonary Tuberculosis, Rifampicin-resistant Tuberculosis
Phase 3 Active, closed Beijing Chest Hospital China

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.

02

Conditions studied

7 conditions
Condition (as registered)Trials
Pulmonary Tuberculosis3
Tuberculous Meningitis2
Tuberculosis2
Tuberculosis, Pulmonary1
Tuberculosis, Lymph Node1
Mycobacterium Tuberculosis1
Rifampicin-resistant Tuberculosis1
03

Sponsors

lead sponsor per trial
Lead sponsorTrials
National Institute of Allergy and Infectious Diseases (NIAID)3
Indian Council of Medical Research1
Johns Hopkins University1
Shenzhen Third People's Hospital1
Beijing Chest Hospital1
04

Trials by country register

RegisterPyrazinamide trials
Clinical trials in India5
Clinical trials in China2

A trial with sites in more than one country appears in each of those registers.

How this page is built

Everything on this page is copied from public ClinicalTrials.gov registry records โ€” it is not written from memory, and nothing here describes how Pyrazinamide works or whether it is effective. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Pyrazinamide (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician โ€” our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us โ€” we correct promptly and log it.